Supriya Lifescience Ltd., a leading API manufacturer, has strengthened its sustainability efforts with the launch of a state-of-the-art 5 MWp solar power facility in Nanded District, Maharashtra. The project was inaugurated by Dr. Satish Wagh, chairman of Supriya Lifescience, who highlighted the company’s commitment to renewable energy and environmental responsibility.

With this addition, the company’s total installed solar capacity has reached 9.85 MWp, building on the existing 4.85 MWp facility in Solapur District. These solar initiatives help reduce dependence on fossil fuels and support India's broader climate goals by fostering a cleaner, more sustainable energy landscape.

Dr. Wagh emphasized that investing in renewable energy aligns with Supriya Lifescience’s long-term vision of sustainable growth and environmental impact reduction. The latest project was executed in collaboration with Enrich Energy Pvt. Ltd., a leader in renewable energy solutions. By integrating solar energy into its pharmaceutical operations, Supriya Lifescience continues to lead in green innovation and energy efficiency.

Founded in 1987, Supriya Lifescience is a globally recognized producer of active pharmaceutical ingredients (APIs). Its cutting-edge manufacturing facility in Khed, Ratnagiri, holds certifications from Health Canada, EUGMP, EDQM, US FDA, and NMPA. With its commitment to sustainability, the company is contributing to India’s renewable energy transition while maintaining excellence in pharmaceutical manufacturing.